Dr. Raf Celus
Turnover is estimated at about €410,000, probably between €330,000 and €520,000. The micro format does not state turnover.
Balance sheet
balance sheet total €449,436 on 31-12-2025in euro
in euro
Position in the sector
94.5%
Higher than 91% of the 21,373 companies filing micro accounts in human health (NACE 86) in 2025.
15.10
Higher than 89% of the 20,922 companies filing micro accounts in human health (NACE 86) in 2025.
36.2%
Higher than 72% of the 21,223 companies filing micro accounts in human health (NACE 86) in 2025.
Net result: top quarter · Equity: top quarter · Balance sheet total: middle half · Working capital: top quarter
Key figures and ratios
per financial year, computed from the annual accounts| Line | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| 226,594 | 209,839 | 173,241 | ||
| 177,757 | 155,481 | 130,084 | ||
| 10,430 | 2,733 | 102,659 | ||
| 321,092 | -103,471 | - | ||
| 349,500 | 182,173 | 67,431 | ||
| 94.5% | 88.1% | 50.4% | ||
| 15.10 | 6.17 | 1.85 | ||
| 0.06 | 0.13 | 0.98 | ||
| 38.3% | 54.4% | 98.3% | ||
| 36.2% | 47.9% | 49.6% | ||
| 74.44 | 60.44 | 47.66 |
A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.
Filed annual accounts
as filed with the National Bank, click a year to choose it| Line | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Balance sheet: assets | ||||
20/58 |
449,436 | 297,203 | 237,019 | |
21/28 |
75,140 | 79,771 | 90,028 | |
21 |
62,500 | 75,000 | 87,500 | |
22/27 |
12,640 | 4,771 | 2,528 | |
23 |
7,890 | 3,786 | 1,423 | |
24 |
3,272 | - | - | |
26 |
1,478 | 985 | 1,105 | |
29/58 |
374,296 | 217,432 | 146,991 | |
40/41 |
2,885 | 267 | - | |
41 |
2,885 | 267 | - | |
50/53 |
- | 160,000 | - | |
54/58 |
344,703 | 23,611 | 127,082 | |
490/1 |
26,708 | 33,554 | 19,909 | |
| Balance sheet: equity and liabilities | ||||
10/49 |
449,436 | 297,203 | 237,019 | |
10/15 |
424,640 | 261,944 | 119,453 | |
10/11 |
2,000 | 2,000 | 2,000 | |
13 |
422,640 | 259,944 | 117,453 | |
133 |
422,640 | 259,944 | 117,453 | |
17/49 |
24,796 | 35,259 | 117,566 | |
42/48 |
24,796 | 35,259 | 79,560 | |
44 |
2,076 | 113 | - | |
440/4 |
2,076 | 113 | - | |
45 |
10,885 | 25,407 | 14,522 | |
450/3 |
10,885 | 25,407 | 14,522 | |
47/48 |
11,835 | 9,739 | 65,038 | |
492/3 |
- | - | 38,006 | |
| Income statement | ||||
76A |
- | 342 | - | |
9900 |
227,281 | 212,331 | 180,281 | |
630 |
15,061 | 12,990 | 12,631 | |
640/8 |
687 | 2,492 | 7,040 | |
9901 |
211,533 | 196,849 | 160,610 | |
75/76B |
5,819 | - | - | |
75 |
5,819 | - | - | |
65/66B |
3,044 | 3,472 | 3,635 | |
65 |
3,044 | 3,472 | 3,635 | |
9903 |
214,308 | 193,377 | 156,975 | |
67/77 |
51,612 | 50,886 | 39,522 | |
9904 |
162,696 | 142,491 | 117,453 | |
9905 |
162,696 | 142,491 | 117,453 | |
| Appropriation of the result | ||||
9906 |
162,696 | 142,491 | 117,453 | |
691/2 |
162,696 | 142,491 | 117,453 | |
6921 |
162,696 | 142,491 | 117,453 | |
| Document | ||||
The full notes are in the filed accounts (PDF).
Source: Annual accounts 2025 (PDF), filed on 01-04-2026.
Filings
each dot is a set of accounts, on the day it reached the National BankInvestments
fixed assets acquired| Item | 2025 | 2024 | 2023 |
|---|---|---|---|
| Tangible fixed assets | €10,430 | €2,733 | €2,659 |
| Intangible fixed assets | - | - | €100,000 |
| €15,061 | €12,990 | €12,631 |
Source: notes to the 2023 to 2025 annual accounts (statement of fixed assets)
Insights on Dr. Raf Celus
The operating result for 2025 is 7% higher than in 2024 and the highest since 2023. It is the second rise in a row.
Debt's share of the balance-sheet total falls from 11.9% to 5.5%. Equity is higher and debt is lower.